HB 2158 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

PRINTER'S NO.   2792

                     THE GENERAL ASSEMBLY OF PENNSYLVANIA



                         HOUSE BILL
                         No. 2158
                                                Session of
                                                  2026

     INTRODUCED BY DAY, KUZMA, PUGH, WALSH, SHAFFER, ZIMMERMAN AND
        HEFFLEY, JANUARY 23, 2026

     REFERRED TO COMMITTEE ON JUDICIARY, JANUARY 26, 2026


                                    AN ACT
 1   Amending the act of April 14, 1972 (P.L.233, No.64), entitled
 2      "An act relating to the manufacture, sale and possession of
 3      controlled substances, other drugs, devices and cosmetics;
 4      conferring powers on the courts and the secretary and
 5      Department of Health, and a newly created Pennsylvania Drug,
 6      Device and Cosmetic Board; establishing schedules of
 7      controlled substances; providing penalties; requiring
 8      registration of persons engaged in the drug trade and for the
 9      revocation or suspension of certain licenses and
10      registrations; and repealing an act," further providing for
11      schedules of controlled substances.
12      The General Assembly of the Commonwealth of Pennsylvania
13   hereby enacts as follows:
14      Section 1.    Section 4(1) of the act of April 14, 1972
15   (P.L.233, No.64), known as The Controlled Substance, Drug,
16   Device and Cosmetic Act, is amended by adding a subclause to
17   read:
18      Section 4.    Schedules of Controlled Substances.--The
19   following schedules include the controlled substances listed or
20   to be listed by whatever official name, common or usual name,
21   chemical name, or trade name designated.
22      (1)   Schedule I--In determining that a substance comes within
 1   this schedule, the secretary shall find: a high potential for
 2   abuse, no currently accepted medical use in the United States,
 3   and a lack of accepted safety for use under medical supervision.
 4   The following controlled substances are included in this
 5   schedule:
 6      * * *
 7      (ix)     Any material, compound, mixture or preparation that
 8   contains 7-hydroxymitragynine in a concentration equal to or
 9   exceeding 2% of the total alkaloid content or 1 milligram per
10   recommended serving size, or any synthetic, semi-synthetic or
11   chemically manipulated form of mitragynine, 7-
12   hydroxymitragynine, mitragynine pseudoindoxyl or any other
13   synthetic, semi-synthetic or chemically manipulated alkaloid,
14   metabolite, derivative or analogue of the Mitragyna speciosa
15   plant.
16      * * *
17      Section 2.    This act shall take effect in 60 days.




20260HB2158PN2792                    - 2 -